APA (7th ed.) Citation

Bonafont, J., & Haußer-Siller, I. (2019). Clinically relevant correction of recessive dystrophic epidermolysis bullosa by dual sgRNA CRISPR/Cas9-mediated gene editing. Molecular therapy, 27(5), . https://doi.org/10.1016/j.ymthe.2019.03.007

Chicago Style (17th ed.) Citation

Bonafont, Jose, and Ingrid Haußer-Siller. "Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual SgRNA CRISPR/Cas9-mediated Gene Editing." Molecular Therapy 27, no. 5 (2019). https://doi.org/10.1016/j.ymthe.2019.03.007.

MLA (9th ed.) Citation

Bonafont, Jose, and Ingrid Haußer-Siller. "Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual SgRNA CRISPR/Cas9-mediated Gene Editing." Molecular Therapy, vol. 27, no. 5, 2019, https://doi.org/10.1016/j.ymthe.2019.03.007.